Conmed Corp
NYSE:CNMD
Conmed Corp
Operating Income
Conmed Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Conmed Corp
NYSE:CNMD
|
Operating Income
$121.4m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Conmed Corp's Operating Income?
Operating Income
121.4m
USD
Based on the financial report for Dec 31, 2023, Conmed Corp's Operating Income amounts to 121.4m USD.
What is Conmed Corp's Operating Income growth rate?
Operating Income CAGR 10Y
4%
Over the last year, the Operating Income growth was 73%. The average annual Operating Income growth rates for Conmed Corp have been 25% over the past three years , 7% over the past five years , and 4% over the past ten years .